IMMUNE STUDIES IN ORAL-CONTRACEPTIVE USERS

被引:7
作者
RAMALAKSHMI, BA
JAGADEESAN, V
PREMA, K
机构
[1] National Institute of Nutrition Indian Council of Medical Research Jamai Osmania (P.O.)
关键词
D O I
10.1016/S0010-7824(79)80051-7
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Some of the parameters of immune status - percentageof B and T lymphocyte subpopulation, PHA-induced lymphocyte transformation measured by 3H-thymidine incorporation (PILT) and levels of total haemolytic complement (CH50) were studied in Indian women from low income group who were using estrogen-progestogen combination pills. There were no differences in percentage of B and T lymphocyte subpopulation or PILT between OC users and the control group. However, CH50 levels were significantly lower in OC users. The depression in circulating complement levels in OC users is intriguing and suggests the possibility that complement system and circulating immune complexes may be altered in OC users. © 1979 Geron-X,Inc.
引用
收藏
页码:417 / 425
页数:9
相关论文
共 25 条
  • [1] ABLIN RJ, 1975, LANCET, V2, P1266
  • [2] BARNES EW, 1974, LANCET, V1, P898
  • [3] SOME IMMUNE-RESPONSES OF GAMBIAN WOMEN TAKING COMBINED ORAL-CONTRACEPTIVE PILL
    BRAY, RS
    [J]. CONTRACEPTION, 1976, 13 (04) : 417 - 425
  • [4] CHANDRA RK, 1972, J REPROD FERTIL, V28, P463
  • [5] DAVIS JC, 1974, LANCET, V2, P217
  • [6] DENMAN AM, 1977, IMMUNOLOGY MEDICINE, P299
  • [7] FALLIERS CJ, 1974, LANCET, V2, P515
  • [8] GERRETSEN, 1975, LANCET, V2, P347
  • [9] HAGEN C, 1972, LANCET, V1, P1185
  • [10] HAINES RF, 1967, FED PROC, V26, P934